Ravioli Stocks

Pernix Therapeutics to Acquire Somaxon Pharmaceuti

SOMX, Somaxon Pharmaceuticals, Inc.

** Pernix Therapeutics Holdings, Inc. and SOMX reported that they have entered into a definitive merger agreement for Pernix to acquire SOMX in a stock-for-stock transaction with a total equity value of $25 million.

Under the terms of the agreement, which has been unanimously approved by the boards of directors of both companies, SOMX stockholders will receive aggregate consideration equal to $25 million in Pernix common stock.

SOMX is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and/or high-level of patient dissatisfaction, currently in the central nervous system therapeutic area.

More about SOMX at www.somaxon.com

********************************

Read Full Disclaimer at http://pennyomega.com/disclaimer